Browse the complete record of transactions filed by Robertson Michelle, 首席财务官. Insider active across 3 companies, notably Editas Medicine, Inc.. Aggregated, 16 filings have been published. Split: 0 buy · 8 sells. Total volume traded: €133k. Activity tracked since 28 June 2021. The latest transaction was filed on 18 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Robertson Michelle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Michelle Robertson is Chief Financial Officer and appears in 16 filings. Across the 16 sampled filings between 2021-06-30 and 2026-02-19, sale amounts total EUR 133399 and the most frequent transaction nature is Sale, with filings tied to Editas Medicine, Inc. and Geron Corp. and Verastem, Inc.